Honey Feast, Inc.

Warning LetterClosed

Charles E. Sanford Owner Honey Feast, Inc. 6906 Lake Nellie Rd. Clermont , FL 34714-8368 United States charlie@honeyfeast.comIssued Mar 17, 2022Office of Human and Animal Food Operations East Division IV

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateMar 17, 2022

Product TypeDrugs

StatusClosed

Closeout LetterJul 15, 2022

Letter Details

Firm: Honey Feast, Inc.
Location: Charles E. Sanford Owner Honey Feast, Inc. 6906 Lake Nellie Rd. Clermont , FL 34714-8368 United States charlie@honeyfeast.com
FEI Number: N/A
Country: United States
Issue Date: March 17, 2022
Issuing Office: Office of Human and Animal Food Operations East Division IV
Product Type: Drugs
Status: Closed
Closeout Letter: July 15, 2022

Summary

Honey Feast, Inc. was cited for marketing honey products (Raw Honeycomb, Tupelo Honey Raw, and Superfood Honey with Royal Jelly, Bee Pollen, Propolis) as drugs without FDA approval by making disease claims on their website. The company's website contained multiple unsupported therapeutic claims, including that their products could treat H. pylori bacteria and stomach ulcers, suppress coughs, kill bacteria in wounds, and boost immunity and prevent cancer. These claims violated the Federal Food, Drug, and Cosmetic Act by establishing the products as intended for use in the cure, mitigation, treatment, or prevention of disease, thereby requiring them to be approved as new drugs before marketing.

Honey Feast, Inc. FDA Warning Letter, March 17, 2022